Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

U.S. Risks Losing Biotech Leadership to China, Congressional Commission Warns

by Team Lumida
April 8, 2025
in Macro
Reading Time: 4 mins read
A A
0
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • A congressional commission has urged the U.S. to invest at least $15 billion in biotechnology research and manufacturing over the next five years to counter China’s rapid advances in the field.
  • Recommendations include barring U.S. companies working with national security agencies from collaborating with Chinese biotech suppliers and creating a National Biotechnology Coordination Office.
  • China’s 20-year focus on biotechnology has made it a global leader, with significant innovation in drug development, agriculture, and potential military applications.
  • Western pharmaceutical companies and venture capitalists are increasingly partnering with Chinese biotech firms, further boosting China’s dominance.

What Happened?

The National Security Commission on Emerging Biotechnology released a report warning that China’s rapid progress in biotechnology poses a significant threat to U.S. national security and global leadership in the field. The report highlights China’s strategic prioritization of biotech over the past two decades, which has transformed it into a hub for innovation in drug development, agriculture, and other critical sectors.

The commission called for immediate action, including a $15 billion investment in biotech research, the creation of a National Biotechnology Coordination Office, and restrictions on U.S. companies working with Chinese biotech suppliers deemed a national security risk.


Why It Matters?

China’s growing dominance in biotechnology could have far-reaching implications for U.S. national security, economic competitiveness, and global influence. Beyond medical advances, biotechnology has applications in agriculture and defense, raising concerns about potential misuse or “weaponization” of the technology.

The U.S. has historically led in biotech innovation, but the report warns that without significant investment and strategic action, the country risks falling behind permanently. The recommendations aim to harness the strengths of the U.S. innovation ecosystem, including private sector partnerships, research institutions, and capital markets, to maintain leadership in this critical field.


What’s Next?

Congress will need to act on the commission’s recommendations, including reallocating resources to prioritize biotech research and manufacturing. The proposed $15 billion investment would fund initiatives such as a national biotech strategy, research centers, and manufacturing plants for defense-related products.

The U.S. must also strengthen partnerships with allies to ensure responsible use of biotechnology and counter China’s influence. However, translating these recommendations into actionable policies will require bipartisan support and collaboration between government, industry, and academia.

Source
Previous Post

Trump Demands Trade Deficit Resolution Before Any Deal With China Amid Global Market Turmoil

Next Post

Americans’ $35 Trillion in Housing Wealth Comes With Rising Costs and Financial Challenges

Recommended For You

Senate Passes the BAAJA Permitting Bill 62-33, Splitting Democrats, in a Push to Speed Energy and Data-Center Projects

by Team Lumida
1 day ago

The Senate voted 62-33 on Thursday to pass the BAAJA permitting bill, which now heads to the House with President Donald Trump’s support.

Read more

Fed Governor Lisa Cook Says Inflation Has Been Above Target for More Than Five and a Half Years and Warns Against Waiting to Hike

by Team Lumida
1 day ago

Lisa Cook said Friday that inflation has been above target for more than five and a half years and that waiting to raise rates risks larger increases later.

Read more

Gold Falls 2.81% to $3,520, Heading for Its Worst Week in Eight Months, Down About 8.9%, as Rate-Hike Bets Overwhelm Haven Demand

by Team Lumida
1 day ago

Spot gold fell 2.81% to $3,520.05 on Friday, on track for its worst week in eight months, down about 8.9%, as December Fed hike bets weighed on bullion.

Read more

Treasury Yields Tumble, With the 10-Year Down 12 Basis Points to 4.932%, as Investors Flee to Havens Ahead of a Likely December Fed Hike

by Team Lumida
1 day ago

The 10-year Treasury yield fell 12 basis points to 4.932% and the 2-year dropped more than 14 basis points to 4.634% as stocks sold off on Friday.

Read more

Gold Hovers Near $3,725, Close to Its Lowest Close Since September 2025, as Fed Minutes Show Nearly All Officials Expect More Rate Hikes

by Team Lumida
3 days ago

Gold traded near $3,725 an ounce, close to a 14-month low and down about 30% since the US-Iran war began, as the Fed signaled more rate hikes.

Read more

Foreign Holdings of US Treasuries Fall $75.5 Billion to $9.24 Trillion, the Biggest Drop Since March, Even as South Korean Investors Buy a Record $11.5 Billion

by Team Lumida
3 days ago

Foreign holdings of Treasuries fell $75.5 billion in September to a one-year low, led by China and France, while Korean investors bought a record amount.

Read more

Fed’s Waller Says the Fed May Need to ‘Shock People’ With a Half-Point Hike in December, Sending the 2-Year Treasury Yield Up More Than 4 Basis Points to 4.83%

by Team Lumida
3 days ago

Waller said a 50 basis point hike is probably needed at the Dec. 8-9 meeting, and the 2-year Treasury yield jumped more than 4 basis points to 4.83%.

Read more

Treasuries Gain for a Third Day as the 10-Year Yield Slips 3 Basis Points to 5.08%, With Traders Saying Much of the Fed’s Coming Rate Hikes Is Already Priced In

by Team Lumida
4 days ago

US Treasuries edged higher for a third day, with the 10-year yield down 3 basis points to 5.08% and the 2-year at 4.78%, as hike expectations look priced...

Read more

Iran Says It Struck U.S. Drone and Missile Sites in Kuwait as Gulf Attacks Mount, Yet WTI Settles Down 1.2% at $84.90 and Brent Slips to $92.70 on Recovering Hormuz Flows

by Team Lumida
4 days ago

Iran claimed strikes on U.S. sites in Kuwait as the war enters its ninth month, but crude settled lower on signs of recovering Hormuz flows.

Read more

Trump, Xi and Putin Converge on Shenzhen for APEC With a Trade Truce Expiring in January 2027, $30 Billion of Promised Tariff Cuts Unscheduled and Nvidia’s China Chip Scandal in the Background

by Team Lumida
4 days ago

Trump and Xi are expected to meet in Shenzhen this week to implement their trade deal, with Nvidia chips, tariffs and the Iran war all in play.

Read more
Next Post
gray wooden house

Americans’ $35 Trillion in Housing Wealth Comes With Rising Costs and Financial Challenges

turned on iPhone on top of brown wooden surface

Trump’s Tariffs Spark iPhone Buying Frenzy as Consumers Brace for Price Hikes

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

KOSPI’s Recent Selloff Signals Broader Reassessment of AI Growth Valuations; Memory Sector Profit Margins Questioned as Supply Tailwinds Viewed as Temporary

KOSPI’s Recent Selloff Signals Broader Reassessment of AI Growth Valuations; Memory Sector Profit Margins Questioned as Supply Tailwinds Viewed as Temporary

October 14, 2026
Prediction Markets Are Going Full Crypto — Kalshi and Polymarket Both Launching Leveraged Perpetual Futures

World Cup Is Over and So Is the Prediction Market Hype Cycle — Polymarket Volume Craters 56%, Kalshi Gains Ground as the Two Giants Diverge

August 12, 2026
OpenAI President Greg Brockman Joins Altman at Trump-Xi Dinner; $25M MAGA Inc. Donor; Strengthens OpenAI’s White House AI Policy Access

OpenAI President Greg Brockman Joins Altman at Trump-Xi Dinner; $25M MAGA Inc. Donor; Strengthens OpenAI’s White House AI Policy Access

September 22, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018